Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Imaging Tool Increases Safety of Brain Surgery

By HospiMedica International staff writers
Posted on 25 Oct 2015
A new stimulated Raman scattering (SRS) microscopic technology may help surgeons differentiate between tumor and normal brain tissue in real-time.

Under development at the University of Michigan Health System (U-M; Ann Arbor, MI, USA), New York University (NYU; NY, USA), and other institutions, the SRS microscopy technique is used to produce different signals for proteins and lipids, which can then be assigned a color—blue and green, respectively—to differentiate between brain cortex, tumor tissue, and white matter. More...
To make the approach amenable to routine use in neuropathology, the researchers created an objective classifier that integrates image characteristics (such as protein/lipid ratio, axonal density, and degree of cellularity), into one output that can alert pathologists to tumor infiltration.

The classifier was built using more than 1,400 images from patients with glioblastoma and epilepsy, and can distinguish between tumor-infiltrated and non-tumor regions with over 99% accuracy, regardless of tumor grade or histologic subtype. A subsequent study of biopsies taken from adult and pediatric patients with glioblastoma revealed not only distinctive features with SRS microscopy, but also the presence of infiltrating cells in tissues that appeared otherwise normal when examined with traditional staining techniques. The study was published on October 14, 2015, in Science Translational Medicine.

“SRS imaging technology could be used to complement existing neurosurgical workflows, allowing for rapid and objective characterization of brain tissues and, in turn, clinical decision-making,” concluded lead author neurosurgeon Daniel Orringer, MD, of U-M, and colleagues. “It allows the surgical decision-making process to become data driven instead of relying on the surgeon's best guess. We're able to visualize tumor that otherwise would be invisible to the surgeon in the operating room.”

“This technology has the potential to resolve a long-standing issue in cancer surgery, which is the need for faster and more effective methods to assess whether a tumor has been fully removed,” added Richard Conroy, PhD, of the US National Institutes of Health (NIH; Bethesda, MD, USA), which provided funding for the development of the technology. “The ability to determine tumor margins without having to send samples to a pathologist could increase patient safety and improve outcomes by shortening the length of surgeries and reducing the number of cases where cancer cells are left behind.”

Related Links:

University of Michigan Health System
New York University
US National Institutes of Health



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.